Formulation of Irbesartan by Microcrystal Technology for Enhancing the Solubility and Dissolution Properties
DOI:
https://doi.org/10.37285/ijpsn.2013.6.2.9Abstract
The aim of this study was to develop the formulation of irbesartan by microcrystal technology to enhance the solubility and dissolution property of the drug. The area of interest in the study carried out is Class II drugs cited in the Biopharmaceutical Classification System. Microcrystal technology is a new carrier-free colloidal drug delivery system with reduced drug particle size and is considered a viable strategy in drug delivery to develop formulations of poorly soluble drugs. In the present study, an attempt was made to enhance the solubility of the drug irbesartan compared to its pure form by microcrystal technology. Drug microcrystals were prepared by the anti-solvent precipitation process. The specified amount of drug was dissolved in methanol and PVP K30 was dissolved in water. The two phases were mixed instantaneously, wherein the drug solution was kept on continuous stirring and the aqueous phase was added to this continuous phase. The particle size of the drug was not reduced, but enhancement in solubility and dissolution properties of the drug were still observed. This could be due to the wettability property of PVP K30. The FT-IR spectra and DSC thermograms confirmed no interference of drug and the stabilizer. XRD studies confirmed the formation of crystals of the drug irbesartan. Thus, it could be concluded that microcrystal technology is a promising approach for solubility enhancement of irbesartan.
Downloads
Metrics
Keywords:
Poor solubility, Irbesartan, PVP K30, microcrystals, solubility enhancement
Downloads
Published
How to Cite
Issue
Section
References
Aruna MS, Babu AK, Thadanki M and Gupta ME (2011). Solid dispersion- An approach to enhance the dissolution rate of Irbesartan. Int J Res Pharm Chem 1: 780-788.
Bindu MB, Kusum B and Banji D (2010). Novel strategies for poorly water soluble drugs. Int J Pharm Sci Rev Res 4: 76-84.
Chawla G and Bansal AK (2007). A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. Eur J Pharm Sci 32: 45–57.
Cirri M, Mura P, Rabasco AM, Gines JM, Moyano JR and Gonzalez-Rodriguez ML (2004). Characterization of Ibuproxam Binary and Tertnary Dispersions with Hydrophilic carriers. Drug Dev Ind Pharm 30: 65-74.
Higuchi T and Connors K (1965). Phase solubility techniques. Adv Anal Chem Instrum 4: 117-123.
Keraliya RA, Tejal G, Soni B, Vaishali T, Thakkar B, Tejal R, Gandhi B, Rajanikant C and Patel A (2010). Formulation and Physical characterization of microcrystals for dissolution rate enhancement of Tolbutamide. Int J Res Pharm Sci 1: 69-77.
Lobenberg R and Amidon GL (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 50: 3–12.
Mahapatra A (2011). Dissolution enhancement and physicochemical characterization of Valsartan in solid dispersions with β-CD, HP β-CD, and PVP K-30. Disso Tech 6: 39-45.
Marcilio SS, Cunha-Filho, Pacheco RM and Landin M (2008). Dissolution rate enhancement of the novel antitumoral β-lapachone by solvent change precipitation of microparticles. Eur J Pharm Biopharm 69: 871–877.
Martinez M, Augsburger L, Johnston T and Jones WW (2002). Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I. Bio-pharmaceutics and formulation considerations. Adv Drug Deliv Rev 54: 805–824.
Modi A and Tayade P (2006). Enhancement of Dissolution Profile by solid dispersion (kneading) Technique. AAPS PharmSciTech 7: 68.
Patel J, Patel A, Raval M and Sheth N (2011). Formulation and development of a selfnano emulsifying drug delivery system of irbesartan. J Adv Pharm Tech Res 2: 9-16.
